CTLA4 and cancer: In the present investigation, in which we used a different model of the transplantable cancer and the ultra-low dose WBIs rather than high-dose localized radiation, addition of the blockers of CTLA-4, PD-1, and/or HSP90 hardly improved the well-pronounced anti-neoplastic effect of WBI.